TOXICOLOGY AND PHARMACOLOGY OF ANTICARCINOGENIC AGENTS

抗癌剂的毒理学和药理学

• 批准号: 3629544
• 负责人: DONALD L HILL
• 金额: $ 35.17万
• 依托单位: SOUTHERN RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1984
• 资助国家: 美国
• 起止时间: 1984-09-30 至 1988-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3629544
• 关键词: disease /disorder model; drug adverse effect; drug metabolism; neoplasm /cancer pharmacology; toxicant screening

Expedite the development of new anticarcinogenic agents. These studies will be linked in large measure to other projects in biological and chemical prevention of carcinogenesis programs, which will provide the agents to be investigated and the means for testing agents for efficacy in anticarcinogenesis.

加快抗癌新药的开发。 这些研究 将在很大程度上与其他生物和 化学预防致癌计划，这将提供 待研究的药剂和测试药剂在以下方面的功效的方法： 抗癌作用